<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for GIVN</title>
    <link />
    <description>Headlines for Given Imaging Ltd.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Oversold Conditions For Given Imaging (GIVN)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11926312/1/oversold-conditions-for-given-imaging-givn.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 16 May 2013 16:51:00 GMT</pubDate>
    </item>
    <item>
      <title>Given Imaging Goes Red</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/09/given-imaging-goes-red/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 09 May 2013 17:06:29 GMT</pubDate>
    </item>
    <item>
      <title>Biolase Gets FDA Nod for EPIC 10S - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97085/biolase-gets-fda-nod-for-epic-10s.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 15 Apr 2013 16:20:01 GMT</pubDate>
    </item>
    <item>
      <title>Haemonetics Back to Neutral - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97072/haemonetics-back-to-neutral.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 15 Apr 2013 14:40:01 GMT</pubDate>
    </item>
    <item>
      <title>Cyberonics Stands Out at Outperform - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96975/cyberonics-stands-out-at-outperform.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 12 Apr 2013 14:20:01 GMT</pubDate>
    </item>
    <item>
      <title>Thoratec Upgraded to Neutral - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96974/thoratec-upgraded-to-neutral.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 12 Apr 2013 14:10:01 GMT</pubDate>
    </item>
    <item>
      <title>LIFE Takeover Battle Heats Up - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96863/life-takeover-battle-heats-up.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 11 Apr 2013 14:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Will Thermo Fisher Buy LIFE? - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96775/will-thermo-fisher-buy-life.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 10 Apr 2013 17:00:01 GMT</pubDate>
    </item>
    <item>
      <title>New Bioinformatics Tools by LIFE - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96751/new-bioinformatics-tools-by-life.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 10 Apr 2013 14:20:01 GMT</pubDate>
    </item>
    <item>
      <title>ANGO Posts Dismal 3Q Earnings - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96579/ango-posts-dismal-3q-earnings.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 09 Apr 2013 08:40:01 GMT</pubDate>
    </item>
    <item>
      <title>CYBX Resumes Reimbursement Efforts - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96522/cybx-resumes-reimbursement-efforts.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 08 Apr 2013 15:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Another Adoption of Masimo - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96521/another-adoption-of-masimo.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 08 Apr 2013 14:50:01 GMT</pubDate>
    </item>
    <item>
      <title>GHDX to Show Prostate Test Result - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96425/ghdx-to-show-prostate-test-result.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 05 Apr 2013 16:15:01 GMT</pubDate>
    </item>
    <item>
      <title>Milestone for Accuray TomoTherapy - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96409/milestone-for-accuray-tomotherapy.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 05 Apr 2013 14:20:01 GMT</pubDate>
    </item>
    <item>
      <title>Boston Scientific Stays at Neutral - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96315/boston-scientific-stays-at-neutral.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 04 Apr 2013 14:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Mindray to Exhibit at CMEF - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96313/mindray-to-exhibit-at-cmef.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 04 Apr 2013 14:10:01 GMT</pubDate>
    </item>
    <item>
      <title>LIFE Grows AmpliSeq Portfolio - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96234/life-grows-ampliseq-portfolio.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 03 Apr 2013 15:48:01 GMT</pubDate>
    </item>
    <item>
      <title>Abiomed Begins Impella RP Trial - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96156/abiomed-begins-impella-rp-trial.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 03 Apr 2013 08:40:01 GMT</pubDate>
    </item>
    <item>
      <title>HMA Set to Start New JV - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96094/hma-set-to-start-new-jv.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 02 Apr 2013 14:50:01 GMT</pubDate>
    </item>
    <item>
      <title>ResMed Protects Patent Landscape - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96091/resmed-protects-patent-landscape.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 02 Apr 2013 14:20:01 GMT</pubDate>
    </item>
  </channel>
</rss>
